📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-07 12:11
712 analysed today
712
Today
133,601
All-time analysed
40,124
Positive
6,284
Negative
79,373
Neutral
7,752
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
27 announcements match the current filters (relevance ≥ 5).
Rs 200 Cr Nagpur Plant Expansion Announced as Q1 FY27 Revenue Drops 12.5%
Dhanuka Agritech reported a challenging Q1 FY27 with revenue declining 12.56% YoY to Rs 461.93 Cr, impacted by a 40% rainfall deficit in June which delayed sowing. Despite short-term headwinds, the company announced a significant new formulation plant in Nagpur with a Rs 200 Cr outlay and 23,000 MTPA capacity, expected to be operational by April 2028. The company also completed a Rs 70 Cr share buyback at Rs 1,400 per share and is launching 5 new products to drive recovery in the coming quarters.
Confidence: HIGH
What changedDhanuka has committed to a new Rs 200 Cr formulation facility in Nagpur and is actively expanding its international footprint using brands acquired from Bayer.
Why it mattersThe new capacity and international brand rights represent a shift toward higher-margin specialty products and global markets, reducing dependency on the volatile Indian monsoon cycle.
Nagpur Plant Outlay: Rs 200 CrCapex vs Net Worth: ~11.9%Q1 FY27 Revenue: Rs 461.93 CrNagpur Plant Capacity: 23,000 MTPABuyback Price: Rs 1,400 per share
📅 Short termThe stock may face pressure due to the 12.5% revenue decline and subdued Q1 margins, though the buyback at a premium provides some floor.
📈 Long termStructural growth is supported by the Dahej backward integration and the upcoming Nagpur plant, alongside a focus on 9(3) patented molecules which command higher margins.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Climatic dependency (monsoon)
- Execution risk for Nagpur plant (2028 timeline)
- Pricing pressure in the generic agrochemical segment
Key Highlights
Revenue for Q1 FY27 stood at Rs 461.93 Cr, a degrowth of 12.56% compared to Rs 528.29 Cr in Q1 FY26
New manufacturing plant at Nagpur announced with an estimated outlay of Rs 200 Cr and 23,000 MTPA capacity
Completed buyback of 5 lakh equity shares at Rs 1,400 per share, absorbing Rs 70 Cr
Innovation Turnover Index maintained at 13.89% with 5 new products (1 fertilizer, 3 fungicides, 1 herbicide) planned for launch
Rainfall shortfall of 40% in June significantly impacted seasonal demand and sowing activities
👀 What to Watch
Investors should monitor the recovery in Q2 and Q3 volumes as monsoon deficits narrowed to 15% by July-end, and track the execution of the Nagpur formulation plant scheduled for 2028.
Dhanuka Q1 PAT Falls 34.6% to ₹36.3 Cr; Announces ₹200 Cr Nagpur Plant Expansion
Dhanuka Agritech reported a weak Q1 FY27 with revenue declining 12.6% YoY to ₹461.93 Cr, impacted by delayed monsoons and postponed sowing. Profitability saw a sharp contraction as PAT fell 34.6% to ₹36.30 Cr and EBITDA margins dropped from 15.75% to 11.91%. To offset the expiry of incentives at its Udhampur unit, the company announced a ₹200 Cr investment for a new 23,000 MT/Annum plant in Nagpur, expected to be operational by April 2028. Management issued cautious guidance for FY27, expecting only lower single-digit revenue growth and a 200bps decline in EBITDA margins.
Confidence: HIGH
What changedDhanuka's Q1 performance significantly lagged the previous year due to climatic factors, and the company has pivoted to a major new capex cycle in Maharashtra to replace expiring tax-incentivized capacity.
Why it mattersThe ₹200 Cr capex represents approximately 11.9% of the company's net worth, signaling a major commitment to maintaining manufacturing scale despite current margin pressures and industry-wide headwinds.
Q1 PAT Growth (YoY): -34.59%Nagpur Capex Outlay: ₹200 CrCapex vs Net Worth: ~11.9%Proposed Plant Capacity: 23,000 MT/AnnumFY27 Margin Guidance Change: -200bpsBuyback Price: ₹1,400
📅 Short termThe stock may face pressure in the near term due to the sharp earnings miss and the management's cautious outlook on full-year margins.
📈 Long termStructural growth depends on the successful ramp-up of the Dahej technical synthesis facility and the timely completion of the Nagpur plant by 2028 to restore margin profiles.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Adverse climatic conditions impacting demand
- Intense price competition in the domestic market
- Execution risk for the 2028 Nagpur plant timeline
Key Highlights
Revenue from operations declined 12.56% YoY to ₹461.93 Cr in Q1 FY27.
PAT decreased 34.59% YoY to ₹36.30 Cr, with EBITDA margins contracting by 384 bps to 11.91%.
Announced a new ₹200 Cr manufacturing facility in Nagpur with 23,000 MT/Annum capacity.
Management guided for a ~200bps decline in EBITDA margins for the full year FY 2026-27.
Completed a ₹70 Cr buyback of 5 lakh shares at ₹1,400 per share and approved a ₹2/share final dividend.
👀 What to Watch
Investors should monitor the recovery in demand during Q2 following the monsoon onset and track the execution timeline of the Nagpur plant, which is critical for long-term tax efficiency. The impact of 5 upcoming product launches on H2 margins will be a key performance indicator.
Dhanuka Agritech: ‡200 Cr Nagpur Expansion Approved; Q1 PAT Drops 34.6% YoY
Dhanuka Agritech reported a weak Q1 FY27 with revenue declining 12.5% YoY to ‡461.93 Cr and Net Profit falling 34.6% to ‡36.30 Cr. Offsetting the poor results, the board approved a ‡200 Cr investment for a new 23,000 MT/annum pesticide unit in Nagpur, Maharashtra, to be operational by April 2028. The company also completed a ‡70 Cr share buyback in June 2026 at ‡1400 per share and sanctioned a ‡15 Cr loan for an employee stock benefit trust.
Confidence: HIGH
What changedDhanuka has committed to a major new manufacturing hub in Nagpur while simultaneously reporting a sharp contraction in quarterly profitability and completing a capital return via buyback.
Why it mattersThe ‡200 Cr expansion (approx. 12% of net worth) signals long-term confidence in volume growth and logistical efficiency, though current earnings are under pressure from industry headwinds or monsoon-related demand shifts.
Q1 Revenue Growth (YoY): -12.5%Q1 PAT Growth (YoY): -34.6%Nagpur Capex: ‡200 CrCapex vs Net Worth: 11.9%Proposed Capacity: 23,000 MT/AnnumBuyback Price: ‡1400
📅 Short termThe stock may face pressure in the short term due to the double-digit decline in both revenue and profit for the June quarter.
📈 Long termThe Nagpur expansion and backward integration strategy are structurally positive for market share in South and Central India, though benefits will only accrue after FY28.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk for the ‡200 Cr greenfield project
- High sensitivity to monsoon and pest infestation patterns
- Margin compression in the core agrochemical segment
Key Highlights
Q1 FY27 Revenue from operations fell to ‡461.93 Cr from ‡528.29 Cr in the previous year's quarter.
Net Profit for the quarter ended June 2026 dropped significantly to ‡36.30 Cr vs ‡55.50 Cr YoY.
Approved ‡200 Cr capex for a new 23,000 MT/Annum manufacturing unit in Nagpur, expected by April 2028.
Completed buyback of 5,00,000 equity shares at ‡1400 per share, totaling ‡70 Cr on June 20, 2026.
Sanctioned a loan of up to ‡15 Cr to the Dhanuka Employee Stock Benefits Trust for open market share acquisition.
👀 What to Watch
Investors should monitor the recovery in operating margins in upcoming quarters and track the execution milestones of the Nagpur facility, which is a key long-term growth driver.
₹200 Cr Nagpur Expansion Approved; Q1 FY27 Net Profit Declines 34.6% YoY
Dhanuka Agritech has approved a ₹200 crore investment to establish a new 23,000 MT/annum pesticide manufacturing unit in Nagpur, Maharashtra, aimed at serving South and Central Indian markets. This capex represents approximately 10.1% of TTM revenue and is slated for completion by April 2028. However, Q1 FY27 financial results were weak, with revenue falling 12.5% YoY to ₹461.93 crore and net profit dropping 34.6% YoY to ₹36.30 crore. The company also confirmed the completion of a ₹70 crore share buyback at ₹1400 per share in June 2026.
Confidence: HIGH
What changedDhanuka has committed to a major new manufacturing hub in Maharashtra while reporting a significant contraction in quarterly profitability and revenue.
Why it mattersThe Nagpur expansion is strategically significant for reducing logistics costs and lead times in key agricultural belts, but the Q1 earnings miss highlights immediate cyclical or pricing pressures in the agrochemical sector.
Proposed Capacity Addition: 23,000 MT / AnnumInvestment Value: ₹200 CroreInvestment vs TTM Revenue: 10.11%Q1 Net Profit Growth (YoY): -34.6%Buyback Price: ₹1400 per shareTarget Completion Date: April 2028
📅 Short termThe stock may face pressure in the short term due to the double-digit decline in both revenue and net profit for the June quarter.
📈 Long termThe 23,000 MT expansion and focus on logistics efficiency in Nagpur provide a structural growth runway, though benefits will only accrue starting FY29.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk for the new greenfield project
- Cyclical demand dependent on monsoon patterns
- Margin compression as seen in Q1 results
Key Highlights
Approved ₹200 crore investment for a new 23,000 MT/annum manufacturing facility in Nagpur.
Q1 FY27 Revenue decreased to ₹461.93 crore from ₹528.29 crore in the year-ago quarter.
Net Profit for Q1 FY27 fell to ₹36.30 crore, a 34.6% decline compared to ₹55.50 crore in Q1 FY26.
Completed buyback of 5,00,000 equity shares at ₹1400 per share, totaling ₹70 crore.
Nagpur plant expected to be operational by March/April 2028, funded via internal accruals or debt.
👀 What to Watch
Investors should monitor the recovery in quarterly margins and the progress of the Nagpur plant's regulatory approvals, as the current earnings slowdown contrasts with the long-term capacity growth plan.
Rs 200 Cr Capex for Nagpur Plant; Q1 Net Profit Declines 34.6% YoY
Dhanuka Agritech reported a weak Q1 FY27 with revenue declining 12.6% YoY to Rs 461.93 Cr and PAT falling 34.6% to Rs 36.30 Cr, reflecting seasonal volatility. To drive long-term growth, the board approved a significant Rs 200 Cr investment (approx. 12% of net worth) for a new 23,000 MT/annum pesticide unit in Nagpur, Maharashtra. The company also completed a Rs 70 Cr buyback in June 2026 and initiated a Rs 15 Cr employee stock benefit plan. While the quarterly performance was subdued, the expansion signals a strategic move to optimize logistics for South and Central India.
Confidence: HIGH
What changedDhanuka is expanding its manufacturing footprint to Nagpur to improve logistics for South and Central India, while simultaneously managing a sharp quarterly earnings contraction.
Why it mattersThe Rs 200 Cr capex represents a major capacity addition (23,000 MT) that could structurally improve market reach and lead times, though the current quarter shows significant margin pressure.
Q1 Revenue: Rs 461.93 CrQ1 PAT: Rs 36.30 CrProposed Capex: Rs 200 CrCapex vs Net Worth: ~11.9%New Capacity: 23,000 MT/AnnumBuyback Amount: Rs 70 Cr
📅 Short termThe stock may face pressure in the short term due to the double-digit decline in both revenue and profitability compared to the previous year.
📈 Long termThe Nagpur expansion and backward integration at Dahej are structural positives for market share, though the full benefits of the Nagpur plant are only expected by FY29.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Monsoon dependency for demand
- Execution risk for the Rs 200 Cr Nagpur facility
- Margin compression in the generic agrochemical segment
Key Highlights
Revenue from operations fell 12.6% YoY to Rs 461.93 Cr in Q1 FY27 from Rs 528.29 Cr in Q1 FY26
Net profit declined 34.6% YoY to Rs 36.30 Cr, with EPS dropping to Rs 8.06 from Rs 12.31
Approved Rs 200 Cr investment for a new 23,000 MT/annum manufacturing unit in Nagpur
Completed buyback of 5,00,000 shares at Rs 1400 per share, totaling Rs 70 Cr on June 20, 2026
Sanctioned a Rs 15 Cr loan to the Employee Stock Benefits Trust for a new SAR 2026 plan
👀 What to Watch
Monitor the recovery in agrochemical demand during the remaining monsoon season and track the execution of the Nagpur plant, which is expected to be operational by April 2028.
Dhanuka Agritech Completes Extinguishment of 5 Lakh Equity Shares Post-Buyback
Dhanuka Agritech has successfully completed the extinguishment of 5,00,000 equity shares following its recent buyback program. This process has reduced the company's total paid-up equity share capital from 4,50,78,324 shares to 4,45,78,324 shares. As a result of the reduced share base, the promoter group's holding has marginally increased from 69.71% to 69.81%. This reduction in equity is expected to have a positive impact on the company's Earnings Per Share (EPS) and Return on Equity (ROE).
Key Highlights
Extinguished 5,00,000 fully paid-up equity shares with a face value of Rs. 2 each
Total issued and paid-up equity capital reduced to 4,45,78,324 shares (Rs. 8,91,56,648)
Promoter shareholding increased from 69.71% to 69.81% post-extinguishment
Public shareholding adjusted to 30.19% of the total post-buyback capital
👀 What to Watch
Investors should view this as a positive capital allocation move that enhances shareholder value through equity base reduction. No specific action is required as this is the formal conclusion of the previously announced buyback.
Dhanuka Agritech Announces ₹70 Crore Buyback at ₹1,400 Per Share; Offer Opens June 4
Dhanuka Agritech Limited has finalized the Letter of Offer for its buyback of 5,00,000 equity shares at a price of ₹1,400 per share. The total buyback size is ₹70 crore, representing 4.20% of the company's paid-up share capital and free reserves. The offer will be conducted via the tender route, with the record date having passed on May 29, 2026. Small shareholders have been allocated a significantly higher entitlement ratio of 1 share for every 15 shares held.
Key Highlights
Buyback price of ₹1,400 per share represents a premium over the current market price.
Total buyback size is ₹70 crore for 5,00,000 shares, which is 1.11% of total equity.
Tender offer window is scheduled from June 4, 2026, to June 10, 2026.
Small shareholder entitlement ratio is approximately 7.13% (1:15), while the general category is 0.96% (5:518).
The buyback is funded through internal accruals and represents 4.20% of the company's net worth.
👀 What to Watch
Eligible shareholders as of the May 29 record date should consider tendering their shares during the June 4-10 window to capitalize on the ₹1,400 exit price. Small shareholders, in particular, should note their higher entitlement ratio which increases the likelihood of successful acceptance.
Dhanuka Agritech Q4 FY26 PAT Jumps 29.5% to ₹97.77 Cr; Announces ₹70 Cr Buyback
Dhanuka Agritech reported a resilient Q4 FY26 with revenue growing 9% YoY to ₹483.34 crores, despite challenging climatic conditions and global volatility. Net profit surged nearly 30% to ₹97.77 crores, significantly bolstered by GST refunds from its Udhampur unit and improved operational efficiencies. The company announced a ₹70 crore share buyback at ₹1,400 per share and a 100% dividend of ₹2 per share. Management is actively pursuing backward integration at its Dahej plant and expanding the international distribution of products acquired from Bayer.
Key Highlights
Revenue from operations grew 9.3% YoY to ₹483.34 crores in Q4 FY26.
PAT increased by 29.5% to ₹97.77 crores, aided by GST refunds and disciplined cost management.
Board approved a buyback of up to 5 lakh shares at ₹1,400 per share, totaling ₹70 crores.
Recommended a 100% dividend of ₹2 per equity share for the financial year.
Insecticides and Herbicides remained the largest product categories, contributing 41% and 31% to turnover respectively.
👀 What to Watch
The buyback at a premium and consistent dividend payouts reflect strong cash flow and management confidence. Investors should monitor the successful scaling of the Dahej plant and international registrations for long-term value creation.
Dhanuka Agritech Q4 Net Profit Jumps 29.5% to Rs 97.77 Cr; Announces Rs 70 Cr Buyback
Dhanuka Agritech reported a robust Q4 FY26 with net profit rising 29.50% YoY to Rs 97.77 crore, driven by favorable Rabi season conditions. Revenue grew 9.35% YoY to Rs 483.34 crore, while EBITDA saw a 13.79% increase. The company announced a share buyback of 5 lakh shares at Rs 1,400 per share and a final dividend of Rs 2 per share. Furthermore, the board has authorized international expansion into Brazil and Europe to strengthen its global footprint.
Key Highlights
Net Profit for Q4 FY26 increased by 29.50% YoY to Rs 97.77 crore.
Revenue from operations rose 9.35% YoY to Rs 483.34 crore in the March quarter.
Approved a share buyback of up to 5,00,000 equity shares at Rs 1,400 per share, totaling Rs 70 crore.
Recommended a final dividend of 100% (Rs 2 per share) for the financial year 2025-26.
Strategic expansion planned through new wholly-owned subsidiaries in Brazil and European countries.
👀 What to Watch
The strong earnings growth combined with a buyback at a premium and international expansion plans signal high management confidence. Investors may consider holding for long-term gains as the company scales its global presence.
Dhanuka Agritech Q4 PAT Surges 29.5% to ₹97.8 Cr; Announces ₹70 Cr Buyback at ₹1,400/Share
Dhanuka Agritech reported a strong recovery in Q4 FY26 with revenue growing 9.35% YoY to ₹483.34 Crores and PAT jumping 29.5% to ₹97.77 Crores. The company announced a share buyback of up to 5 lakh shares at ₹1,400 per share, alongside a 100% dividend of ₹2 per share. While full-year FY26 revenue remained flat at ₹2,019.79 Crores, the management has guided for lower double-digit revenue growth in FY27. However, EBITDA margins are expected to face a slight compression of approximately 100bps in the coming fiscal year.
Key Highlights
Q4 FY26 PAT increased 29.5% YoY to ₹97.77 Crores, with EBITDA margins expanding to 25.84%.
Board approved a ₹70 Crore buyback of 5 lakh equity shares at a maximum price of ₹1,400 per share.
Innovation turnover index (new molecules) contributed 13.93% to total revenue in FY26.
Management provided FY27 guidance of lower double-digit revenue growth despite a projected 100bps EBITDA margin decline.
Recommended a final dividend of 100% (₹2 per equity share) for the financial year ended March 31, 2026.
👀 What to Watch
Investors should take confidence from the strong Q4 recovery and the premium buyback offer, which signals management's belief in intrinsic value. Monitor the monsoon progression and the impact of the guided 100bps margin decline on FY27 profitability.
Dhanuka Agritech Approves ₹70 Cr Buyback at ₹1,400/Share, ₹2 Dividend & Global Expansion
Dhanuka Agritech's board has approved a share buyback of up to 5,00,000 shares at ₹1,400 per share, representing a total outlay of ₹70 crore via the tender route. The company also declared a final dividend of ₹2 per share (100%) for FY26 with a record date of July 17, 2026. Furthermore, the board approved setting up wholly-owned subsidiaries in Brazil and Europe with an initial investment of ₹1 crore each to facilitate global brand registrations. New employee incentive schemes (ESOP and SARs) were also introduced to align management interests.
Key Highlights
Buyback of 5 lakh shares (1.11% of capital) at ₹1,400 per share via tender offer route.
Total buyback size capped at ₹70 crore with a record date fixed for May 29, 2026.
Final dividend of ₹2 per share (100% of face value) recommended for the financial year 2025-26.
Expansion into Brazil and Europe via new subsidiaries to manage brand registrations and international growth.
Introduction of ESOP 2026 and SARs 2026 plans covering approximately 0.39% of total equity capital.
👀 What to Watch
Investors should note the May 29 record date to be eligible for the tender-route buyback which is priced at a premium. The expansion into Brazil and Europe signals a long-term strategy to scale the export and brand portfolio.
Dhanuka Agritech Approves ₹70 Cr Buyback at ₹1,400/Share and ₹2 Final Dividend
Dhanuka Agritech has announced a multi-pronged corporate action plan including a share buyback of 5,00,000 shares at a price of ₹1,400 per share, which is a significant premium. The board also recommended a 100% final dividend of ₹2 per share for FY26. Strategically, the company is expanding internationally by setting up wholly-owned subsidiaries in Brazil and Europe to manage brand registrations. Furthermore, the company reported audited FY26 results with an unmodified audit opinion and introduced new ESOP and SARs plans to incentivize employees.
Key Highlights
Approved buyback of 5,00,000 equity shares (1.11% of total capital) at ₹1,400 per share via Tender Offer route.
Total buyback size is ₹70 crore with the record date fixed for May 29, 2026.
Recommended a final dividend of ₹2 per share (100% of face value) with a record date of July 17, 2026.
Setting up new subsidiaries in Europe and Brazil with an initial investment of ₹1 crore each for international brand transfers.
Introduced ESOP and SARs Plan 2026 involving up to 1,75,000 shares/units to align employee interests.
👀 What to Watch
Investors should consider the buyback offer given the ₹1,400 price and ensure they hold shares by the May 29 record date to be eligible. The expansion into Brazil and Europe marks a significant step in globalizing their brand portfolio, which warrants long-term monitoring.
Dhanuka Agritech Announces ₹70 Cr Buyback at ₹1,400/Share, ₹2 Dividend and Global Expansion
Dhanuka Agritech has approved a buyback of 5,00,000 equity shares at a price of ₹1,400 per share, totaling ₹70 crore via the tender offer route. The board also recommended a final dividend of ₹2 per share (100%) for FY26, with a record date of July 17, 2026. In a significant strategic move, the company is expanding internationally by setting up wholly-owned subsidiaries in Brazil and Europe with an initial investment of ₹1 crore each. Additionally, new employee incentive schemes (ESOP and SARs) were introduced to align management interests with shareholders.
Key Highlights
Approved buyback of 5,00,000 shares (1.11% of capital) at ₹1,400 per share, a significant premium to market price.
Recommended final dividend of ₹2 per share (100%) for FY 2025-26.
Setting up new subsidiaries in Brazil and Europe for brand registration and global business growth.
Fixed May 29, 2026, as the record date for the ₹70 crore buyback entitlement.
Introduced ESOP 2026 and SARs 2026 schemes covering 0.11% and 0.28% of equity capital respectively.
👀 What to Watch
Investors should consider the buyback record date of May 29, 2026, to participate in the tender offer at a premium. The expansion into Brazil and Europe is a long-term positive for geographical diversification.
Dhanuka Agritech Approves Rs 70 Cr Buyback at Rs 1,400/Share and Rs 2 Final Dividend
Dhanuka Agritech has announced a share buyback of up to 5,00,000 shares at a price of Rs 1,400 per share, representing a significant premium to current market prices. The total buyback size is Rs 70 crore via the tender offer route, with a record date of May 29, 2026. Additionally, the board recommended a final dividend of Rs 2 per share and approved the establishment of new subsidiaries in Europe and Brazil to facilitate global brand registrations. The company also introduced new ESOP and SARs plans to incentivize employees, covering approximately 0.39% of equity capital.
Key Highlights
Buyback of 5,00,000 equity shares (1.11% of capital) at Rs 1,400 per share via tender offer
Total buyback outlay of Rs 70 crore with the record date fixed for May 29, 2026
Recommended final dividend of Rs 2 per share (100% of face value) for FY 2025-26
Expansion into Europe and Brazil through wholly-owned subsidiaries with initial Rs 1 crore investment each
Introduction of ESOP 2026 and SARs 2026 plans involving up to 1,75,000 equity share equivalents
👀 What to Watch
Investors interested in the buyback should ensure they hold shares by the May 29 record date to participate in the tender offer at the premium price. The expansion into international markets and brand acquisitions from Bayer indicate a positive long-term growth trajectory.
Dhanuka Agritech Approves Rs 70 Cr Buyback at Rs 1,400/Share and Rs 2 Final Dividend
Dhanuka Agritech has announced a multi-pronged corporate action including a share buyback of up to 5,00,000 shares at a price of Rs 1,400 per share, totaling Rs 70 crore. The board also recommended a final dividend of 100% (Rs 2 per share) for FY 2025-26, with a record date set for July 17, 2026. Strategically, the company is expanding internationally by setting up wholly-owned subsidiaries in Brazil and Europe to facilitate brand registrations and global growth. Additionally, the board approved new employee incentive schemes (ESOP and SARs) and noted the retirement of senior management personnel.
Key Highlights
Approved buyback of 5,00,000 equity shares (1.11% of total capital) at Rs 1,400 per share via tender route.
Recommended final dividend of Rs 2 per share (100% of face value) with record date of July 17, 2026.
Buyback record date fixed for May 29, 2026, to determine eligibility for the Rs 70 crore offer.
Expansion into Brazil and Europe approved with initial investments of Rs 1 crore per entity.
Introduction of ESOP and SAR plans 2026 covering approximately 0.39% of the equity share capital.
👀 What to Watch
Investors interested in the buyback should ensure share ownership before the May 29 record date to participate in the tender at Rs 1,400. The expansion into high-growth markets like Brazil suggests a positive long-term outlook for geographical diversification.
Dhanuka Agritech Approves ₹70 Cr Buyback at ₹1,400/Share, ₹2 Dividend, and Global Expansion
Dhanuka Agritech has announced a share buyback of up to 5,00,000 shares at ₹1,400 per share, totaling ₹70 crore via the tender offer route. The board recommended a final dividend of ₹2 per share (100% of face value) for FY26, with a record date of July 17, 2026. In a significant strategic move, the company is expanding internationally by setting up wholly-owned subsidiaries in Europe and Brazil with an initial investment of ₹1 crore each. Additionally, the company introduced new ESOP and SARs plans to incentivize employees, representing approximately 0.39% of the total equity capital.
Key Highlights
Approved buyback of 5,00,000 shares (1.11% of capital) at ₹1,400 per share via tender offer
Total buyback size of ₹70 crore with a record date fixed for May 29, 2026
Recommended final dividend of ₹2 per share (100%) for the financial year 2025-26
Setting up new subsidiaries in Europe and Brazil to facilitate global brand registrations
Introduced ESOP 2026 and SARs 2026 plans covering a total of 1,75,000 equity-linked instruments
👀 What to Watch
Investors should monitor the buyback record date of May 29 to participate in the tender offer, which is priced at a premium. The expansion into Brazil and Europe is a positive long-term indicator for international revenue growth.
Dhanuka Agritech Announces Rs 70 Cr Buyback at Rs 1,400/Share and Rs 2 Final Dividend
Dhanuka Agritech has announced a comprehensive capital allocation plan including a final dividend of Rs. 2 per share and a share buyback worth Rs. 70 crore. The buyback is priced at Rs. 1,400 per share, representing a significant premium to support shareholder value. Furthermore, the company is expanding its global footprint by establishing wholly-owned subsidiaries in Brazil and Europe to facilitate brand registrations and international growth. The board also approved new employee stock option and appreciation rights plans to align management interests with long-term performance.
Key Highlights
Recommended a final dividend of Rs. 2 per equity share (100% of face value) for FY 2025-26.
Approved a buyback of 5,00,000 equity shares at Rs. 1,400 per share via tender offer route.
Total buyback size is Rs. 70 crore, representing 1.11% of total paid-up equity capital.
Setting up new subsidiaries in Europe and Brazil with an initial investment of Rs. 1 crore each.
Fixed May 29, 2026, as the record date for the buyback and July 17, 2026, for the final dividend.
👀 What to Watch
Investors should monitor the buyback record date of May 29, 2026, to determine eligibility for the tender offer at the premium price of Rs. 1,400. The expansion into Brazil and Europe marks a strategic shift towards international markets which may drive long-term growth.
Dhanuka Agritech Approves ₹70 Cr Buyback at ₹1,400/Share, ₹2 Dividend, and Global Expansion
Dhanuka Agritech's board has approved a share buyback of up to 5,00,000 shares at a price of ₹1,400 per share, representing a total outlay of ₹70 crore via the tender route. The company also recommended a final dividend of ₹2 per share for FY26, with the record date set for July 17, 2026. Strategically, Dhanuka is expanding its footprint by setting up wholly-owned subsidiaries in Brazil and Europe to facilitate brand registrations and global business growth. Additionally, the board introduced new ESOP and Stock Appreciation Rights plans to incentivize employees, covering approximately 0.39% of the equity capital.
Key Highlights
Approved buyback of 5,00,000 equity shares (1.11% of capital) at ₹1,400 per share via tender offer route.
Recommended a final dividend of 100% (₹2 per share) for FY 2025-26 with a record date of July 17, 2026.
Setting up new subsidiaries in Europe and Brazil with an initial investment of ₹1 crore each for brand transfers.
Fixed May 29, 2026, as the record date for determining eligibility for the ₹70 crore buyback offer.
Introduced ESOP 2026 and SARs 2026 plans involving a total of 1,75,000 equity share equivalents.
👀 What to Watch
Investors should monitor the buyback record date of May 29, 2026, to participate in the tender offer which is priced at a premium. The expansion into Brazil and Europe indicates a strategic shift towards international markets which may drive long-term valuation.
Dhanuka Agritech Q3 FY26 Revenue Drops 8% to ₹410 Cr Amid Weak Agrochemical Demand
Dhanuka Agritech reported a challenging Q3 FY26 with revenue declining 7.9% YoY to ₹409.92 crores and PAT falling 27.3% to ₹40 crores. The performance was hampered by weak demand in South and West India, lower crop prices, and regulatory hurdles in the biologicals segment which caused a ₹49 crore impact over nine months. However, management expressed optimism for Q4, citing a strong start in January and the commercialization of new products from the Dahej plant. The company maintains a healthy cash position of over ₹250 crores and expects biostimulant approvals by the end of the current quarter.
Key Highlights
Revenue from operations decreased to ₹409.92 crores in Q3 FY26 from ₹445.27 crores in Q3 FY25
EBITDA fell significantly to ₹58.66 crores compared to ₹75.56 crores in the previous year's quarter
Regulatory changes in biostimulants led to a significant sales impact of ₹49 crores during the first nine months of FY26
Management targets EBITDA-positive operations for the Dahej plant in FY27 with 80% capacity utilization
Cash and liquid investments remain strong at over ₹250 crores as of December 2025
👀 What to Watch
Investors should monitor the recovery in Q4 and the successful re-launch of biostimulant products in Q1 FY27. While Q3 was weak, the management's commentary on January performance and Dahej plant scaling suggests a potential turnaround.
Dhanuka Agritech Q3 FY26 PAT Drops 27% YoY to ₹40 Cr Amid Weak Agrochemical Demand
Dhanuka Agritech reported a weak set of numbers for Q3 FY26, with revenue from operations declining 7.94% YoY to ₹409.92 Crores. Profitability took a significant hit as PAT fell 27.33% to ₹40 Crores, and EBITDA margins contracted by 266 bps to 14.31%. The company attributed the decline to stressed demand drivers, including adverse weather and low crop prices, particularly in South and West India. Management has issued a cautious guidance for the full year FY26, expecting flat revenue and a 100 bps decline in EBITDA margins.
Key Highlights
Revenue from operations decreased 7.94% YoY to ₹409.92 Crores in Q3 FY26.
EBITDA declined by 22.37% YoY to ₹58.66 Crores, with margins contracting to 14.31%.
Net Profit (PAT) dropped 27.33% YoY to ₹40.00 Crores from ₹55.04 Crores in Q3 FY25.
Management expects flat revenue for FY26 and a margin compression of approximately 100 bps.
Innovation Turnover Index (new molecules) contributed 16.32% to total revenue for 9M FY26.
👀 What to Watch
Investors should exercise caution as the company faces headwinds from weak rural demand and margin pressure. The focus should be on the Dahej plant's progress, which is targeted to become EBITDA positive in FY27.
